EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Biallelic Pathogenic Variants in PYGM Impair Retinal Glycogenolysis Causing a Range of Phenotypes

Rowaida Hussein, Alaa Tayyib, Siying Lin, Deepika Parameswarappa, Maanik Mehta, Aditi Mohla, Kashif Ahmed, Anupreet Tumber, Erika Tavares, Elena R Schiff, Chantal Morel, Graeme Nimmo and 23 more

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.11.18 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Rowaida Hussein and 34 co-authors. Institution: Genetics and Genome Biology, SickKids Research Institute, Toronto, Canada. Major MEDLINE topics: Glycogen Storage Disease Type V, Glycogen Phosphorylase, Muscle Form, Mutation. 98 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Wellcome Trust.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Biallelic pathogenic variants in PYGM (glycogen myophosphorylase) cause glycogen storage disease V (GSDV), a skeletal muscle disorder with reported association with hereditary macular dystrophy (HMD). This study investigated the role of PYGM in HMD and broader retinal disease through clinical and functional analyses.

Methods

An autosomal recessive HMD family underwent phenotyping and genome sequencing. Separately, data from 65 patients with GSDV (mean age = 51.7 years) were analyzed for retinal involvement. Immunohistochemistry, RT-qPCR and translating ribosome affinity purification assays assessed retinal expression of glycogen phosphorylase (GP) isoenzymes. Glycogenolysis was studied in retinal pigment epithelial (RPE-1) cells. Retinal sections from PygmR50*/R50* mice were also examined.

Results

Genome sequencing identified a homozygous pathogenic stop-gain variant in PYGM (NM_005609.4:c.148C > T; p.[Arg50*]) in the proband and affected sibling, and re-phenotyping revealed features of GSDV. Retinal involvement was identified in 30 of 65 GSDV cases (23 bilateral), with higher prevalence in participants >60 years (approximately 2.6-fold) and men (approximately 2-fold). PYGM expression was localized to Müller glia and photoreceptors. Cell-type-specific GP isoenzyme expression was found in mouse retina and RPE-1 cells. RPE-1 cells demonstrated glycogenolysis. PygmR50*/R50* mice lacked glycogen accumulation but exhibited photoreceptor outer segment thinning consistent with Pygm being the predominant isoform expressed in mouse photoreceptors.

Conclusions

GSDV is moderately associated with retinopathy, and may present as non-syndromic HMD, warranting retinal monitoring for patients, and the inclusion of PYGM in retinal dystrophy gene panels. Redundancy in retinal glycogenolysis may account for lower penetrance and higher age-related prevalence in patients. Photoreceptor thinning observed in PygmR50*/R50* mice strengthens the association between HMD and GSDV in humans.

Subjects

MeSH terms (MEDLINE)

Glycogen Storage Disease Type VGlycogen Phosphorylase, Muscle FormMutationHumansMaleAnimalsFemaleMiddle AgedPhenotypeMicePedigreeAdultAgedImmunohistochemistryRetinal Pigment EpitheliumRetinaAlleles

Substances

Glycogen Phosphorylase, Muscle Form

Authors and institutions

  • Genetics and Genome Biology, SickKids Research Institute, Toronto, Canada.
  • Ophthalmology and Vision Sciences, Hospital for Sick Children, Toronto, Canada.
  • Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada.
  • National Institute of Health Research Biomedical Research Centre at Moorfields Eye Hospital, London, United Kingdom.
  • Institute of Ophthalmology, University College London, London, United Kingdom.
  • Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.

Funding

  • Wellcome Trust

Cite

APA

Hussein, R., Tayyib, A., Lin, S., Parameswarappa, D., Mehta, M., Mohla, A., Ahmed, K., Tumber, A., Tavares, E., Schiff, E. R., Morel, C., Nimmo, G., Rajala, A., VandenHoven, C., MacNeill, K., MacDonald, H., Klatt, R., Keane, P. A., Michaelides, M., …, & Vincent, A. (2026). Biallelic Pathogenic Variants in PYGM Impair Retinal Glycogenolysis Causing a Range of Phenotypes. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.11.18

Vancouver

Hussein R, Tayyib A, Lin S, Parameswarappa D, Mehta M, Mohla A, et al. Biallelic Pathogenic Variants in PYGM Impair Retinal Glycogenolysis Causing a Range of Phenotypes. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.11.18

BibTeX
@article{Hussein2026,
  author = {Hussein, Rowaida and Tayyib, Alaa and Lin, Siying and Parameswarappa, Deepika and Mehta, Maanik and Mohla, Aditi and Ahmed, Kashif and Tumber, Anupreet and Tavares, Erika and Schiff, Elena R and Morel, Chantal and Nimmo, Graeme and Rajala, Ammaji and VandenHoven, Cynthia and MacNeill, Katelyn and MacDonald, Heather and Klatt, Regan and Keane, Pearse A and Michaelides, Michel and Sondheimer, Neal and Pizzamiglio, Chiara and Dowd, Nicola and Robson, Anthony G and Webster, Andrew R and Minassian, Berge A and Ivakine, Evgueni and Monnier, Philippe P and Quinlivan, Rosaline and Khan, Kamron and Tarnopolsky, Mark and Rajala, Raju V S and Héon, Elise and Pinós, Tomas and Mahroo, Omar A and Vincent, Ajoy},
  title = {Biallelic Pathogenic Variants in PYGM Impair Retinal Glycogenolysis Causing a Range of Phenotypes},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.11.18}
}
Start for free →